谷氨酸受体对抗剂ifenprodil可以抑制E型肝炎病毒感染
Mara Klöhn1, André Gömer1, Qiyu He2
1Department of Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany.
Antimicrobial agents and chemotherapy
|October 3, 2024
概括
一种已批准的药物伊芬普罗迪尔有效地抑制了细胞培养和动物模型中的肝炎E病毒 (HEV) 复制. 这一发现为治疗HEV感染提供了潜在的新疗法策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肝炎E病毒 (HEV) 感染影响全球数百万人.
- 目前对HEV的治疗方法有限,这凸显了对新的抗病毒疗法的需求.
研究的目的:
- 为了确定HEV感染的新型治疗剂.
- 评估ifenprodil,一个N-甲基-D-酸盐受体 (NMDAR) 抗剂,作为一种潜在的HEV抑制剂.
主要方法:
- 研究了ifenprodil在人类肝瘤细胞和初级人类肝细胞中对HEV的抗病毒活性.
- 在HEV感染的子模型中评估ifenprodil的疗效.
主要成果:
- 伊芬产抑制了HEV蛋白表达和肝细胞中的RNA积累.
- 伊芬普罗迪尔证明了对早期病毒感染阶段的剂量依赖抑制.
- 在受感染的子中,ifenprodil治疗显著降低了便病毒的分泌.
结论:
- 伊芬产是一种强大的HEV复制抑制剂.
- 伊芬产作为治疗乙型肝炎感染的治疗候选药物显示出前途.
相关概念视频
Eukaryotic Transcription Inhibitors
9.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.0K
Hepatitis
74
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
74
Inhibitors of Bacterial Protein Synthesis
94
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
94
Inhibitors of Bacterial DNA Synthesis
119
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
119
Inhibitors of Viral Protein Synthesis
54
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
54
Viral Hepatitis I: Introduction
17
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
17


